Flexibility for Your Patients With CIDP

With convenient weekly dosing, patients can fit Hizentra into their normal routine

Self-administration gives you and your CIDP patients the freedom to choose:


Infusion calendar icon

Your CIDP patient's routine

Infusion timing icon

How long the self-infusions take

Infusion dose icon

How much medicine is given per infusion

Infusion sites icon

How many infusion sites your patients use

Hizentra provides flexibility to personalize treatment for a wide range of patient needs

Clinical Challenges

Primary Immunodeficiency Patient - James

Experiences IV-related systemic adverse reactions

James 45 years old | 210 lb (95 kg)*

Primary Immunodeficiency Patient - Alice

Has venous access issues

Alice 80 years old | 165 lb (75 kg)*

Lifestyle Burdens

Primary Immunodeficiency Patient - Miguel

Requires more frequent IV infusions

Miguel 55 years old | 176 lb (80 kg)*

Primary Immunodeficiency Patient - Allison

Seeks flexibility, freedom, and control

Allison 40 years old | 154 lb (70 kg)*

Flexible infusion schedule chart

Why Hizentra?

  • Switching to subcutaneous infusions may help address systemic ARs so he can get back to living

Dose: 19 g/95mL

Rate of infusion: 40 mL/hr/site

Infusion sites: 2

Time per infusion: 1 hour and 10 minutes

Based on a dose of 0.2g/kg.

Flexible infusion schedule chart
Flexible weekday infusion schedule chart

Why Hizentra?

  • Subcutaneous infusions do not require infusions into a vein or the hassle of installing and maintaining a port

Dose: 15 g/75mL

Rate of infusion: 30mL/hr/site

Infusion sites: 2

Time per infusion: ~1 hour 15 minutes

Based on a dose of 0.2g/kg.

Flexible weekday infusion schedule chart
Twice weekly flexible infusion schedule chart

Why Hizentra?

  • Less volume per infusion means he can infuse in about an hour

Dose: 32 g/160 mL (2 sessions over 2 days)

Rate of infusion: 40mL/hr/site

Infusion sites: 2

Time per infusion: ~1 hour

Based on a dose of 0.4g/kg.

Twice weekly flexible infusion schedule chart
Once weekly Flexible infusion schedule chart

Why Hizentra?

  • Self-infusion where and when she chooses lets her continue her day without missing work or other activities each month

Dose: 28 g/140 mL

Rate of Infusion: 45 mL/hr/site

Infusion sites: 3

Time per infusion: ~1 hour

Based on a dose of 0.4g/kg.

Once weekly Flexible infusion schedule chart

*Rate of infusion and number of infusion sites in these hypothetical case studies are based on recommended rate and volume per site of subsequent infusions.

 Photos do not depict actual patients.

 Recommended subcutaneous dose is 0.2 g/kg body weight (bw) per week.

 In the PATH study, both 0.2 g/kg and 0.4 g/kg doses were found to be safe and effective. Patients who relapsed were restabilized with IVIg.

 During the Open-Label Extension (OLE) study to PATH, patients who relapsed on 0.2 g/kg were titrated to 0.4 g/kg without IVIg restabilization.

In the PATH Study
Most CIDP patients reported Hizentra easy to use5

88% of patients reported Hizentra easy to use* pic chart
  • All patients or caregivers learned to effectively administer Hizentra on their own after 4 or fewer training sessions8
*Based on last postdose observation (n=154). Exploratory endpoint, captured with the TSQM (Treatment Satisfaction Questionnaire for Medication, version 1.4) on a 7-point scale, ranging from extremely difficult to extremely easy. This set was dichotomized into "difficult" for the categories extremely difficult, very difficult, and difficult; and into "easy" for the categories somewhat easy, easy, very easy, and extremely easy.

Self-administration gives patients like James the freedom to infuse at a place and time convenient to them

Patient started Hizentra after years of every 28-day IVIg.

Frequently asked questions about Hizentra for CIDP

Want to know more about Hizentra? We have the answers to prescribers' frequently asked questions.

See the answers
Hizentra dosing and administration for CIDP

Explore helpful tools for and additional information about self-infusing Hizentra.

See dosing options and administration
acuity
You are now leaving the current website.

Do you want to continue?

No Yes